Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between plasma prostaglandin E2 level and colorectal cancer.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) - 1 Jan 2021

Wang Fan, Wang Maoqing, Yin Huihui, Long Zhiping, Zhu Lin, Yu Huan, Sun Hongru, Bi Haoran, Li Shuying, Zhao Yashuang, Dong Xinshu, Zhou Junde

Abstract excerpt

Evidences for the personalized use of nonsteroidal anti-inflammatory drugs (NSAIDs) in colorectal cancer (CRC) prevention and treatment that include consideration of prostaglandin E2 levels are necessary. This study was designed as a case-control study including 60 CRC patients and 120 cancer-free controls. A sensitive empirical method, precolumn derivatization HPLC, was used to determine plasma PGE2 levels. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Cyclooxygenase 2

Share to Dinoprostone

Share to Genotype

Share to Polymorphism, Genetic

Share to Risk Factors

Source

Identifiers

PMID: 33275396
DOI: 10.1097/CEJ.0000000000000583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between plasma prostaglandin E2 level and colorectal cancer.PMID 33275396Read ↗

Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.Semantic proximity Read ↗

The -765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis.Semantic proximity Read ↗

PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.Semantic proximity Read ↗

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.Semantic proximity Read ↗

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal CancerSemantic proximity Read ↗

Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications.Semantic proximity Read ↗

Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical SignificanceSemantic proximity Read ↗

Pharmacogenomics of cyclooxygenases.Semantic proximity Read ↗

Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.Semantic proximity Read ↗

COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.Semantic proximity Read ↗

Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.Semantic proximity Read ↗

A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.